Projects per year
Personal profile
Headline
PROFESSOR Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Louis Aledort is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Finished
-
INTRANASAL DDAVP SPRAY IN MILD HEMOPHILIA AND VON WILLEBRAND'S DISEASE
National Center for Research Resources
1/10/91 → 30/09/92
Project: Research
-
RECOVERY AND HALF-LIFE STUDIES OF FACTOR VII, VIII AND IX
National Center for Research Resources
1/10/89 → 30/09/91
Project: Research
-
SAFETY AND CLINICAL EFFICACY OF RECOMBINANT DNA DERIVED FACTOR VIII
National Center for Research Resources
1/10/89 → 30/09/94
Project: Research
-
IVIG IN TREATMENT OF AUTOIMMUNE &ALLOIMMUNE ANTIBODIES TO COAGULATION FACTORS
National Center for Research Resources
1/10/88 → 30/09/91
Project: Research
-
IMMUNOABSORPTION FOR INHIBITORS TO FACTORS VIII AND IX
National Center for Research Resources
1/10/87 → 30/09/90
Project: Research
-
Are all licensed haemostatic agents for haemophilia therapy accessible to patients?
the International Prophylaxis Study Group, Nov 2022, In: Haemophilia. 28, 6, p. e256-e258Research output: Contribution to journal › Letter › peer-review
-
In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?
Berntorp, E., Krassova, S. & Aledort, L., Nov 2021, In: Haemophilia. 27, 6, p. e762-e764Research output: Contribution to journal › Letter › peer-review
Open Access -
A retrospective observational study of rurioctocog Alfa Pegol in clinical practice in the United States
Aledort, L., Milligan, S., Watt, M. & Booth, J., 1 Apr 2020, In: Journal of managed care & specialty pharmacy. 26, 4, p. 492-503 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Convalescent plasma for administration of passive antibodies against viral agents
Minno, G. D., Mannucci, P. M., Ironside, J. W., Perno, C. F., Gürtler, L. & Aledort, L., Dec 2020, In: Haematologica. 105, 12, p. 2710-2715 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Emicizumab in Hemophilia A. Reply
Aledort, L. M., 20 Feb 2020, In: New England Journal of Medicine. 382, 8, p. 786 1 p.Research output: Contribution to journal › Letter › peer-review
Press / Media
-
Ever Aspirin: 120 years after its invention, Aspirin still reveals new depths
7/05/19
1 item of Media coverage
Press/Media